95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.00%
Revenue growth above 1.5x AEM's 5.48%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-1.07%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.07%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.07%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
8.72%
Positive net income growth while AEM is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.98%
Share count expansion well above AEM's 0.40%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
8.94%
Diluted share count expanding well above AEM's 0.48%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
22.62%
OCF growth at 50-75% of AEM's 31.29%. Martin Whitman would question if the firm lags in monetizing sales effectively.
113.34%
FCF growth above 1.5x AEM's 26.86%. David Dodd would verify if the firm’s strategic investments yield superior returns.
252.80%
Similar 10Y revenue/share CAGR to AEM's 277.63%. Walter Schloss might see both firms benefiting from the same long-term demand.
46.85%
5Y revenue/share CAGR above 1.5x AEM's 6.93%. David Dodd would look for consistent product or market expansions fueling outperformance.
-28.54%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
388.16%
10Y OCF/share CAGR 1.25-1.5x AEM's 294.61%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
38.42%
Positive OCF/share growth while AEM is negative. John Neff might see a comparative advantage in operational cash viability.
-44.68%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
230.32%
Positive 10Y CAGR while AEM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-14.41%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-66.75%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
1009.18%
10Y equity/share CAGR above 1.5x AEM's 235.46%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
105.03%
5Y equity/share CAGR above 1.5x AEM's 2.72%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
37.47%
3Y equity/share CAGR above 1.5x AEM's 0.85%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.64%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
3.32%
Our AR growth while AEM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.23%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-7.41%
We have a declining book value while AEM shows 1.06%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-10.63%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-0.92%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.